Heart Disease Clinical Trials in Ohio

195 recruiting studies across 2 cities

Browse by City

All Trials in Ohio

Phase
Trial Phase Dist.
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase 3<1 mi
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease<1 mi
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products<1 mi
RESPONDER-HF TrialN/A<1 mi
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM<1 mi
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial FibrillationN/A<1 mi
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVRN/A<1 mi
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)N/A<1 mi
The ENCIRCLE TrialN/A<1 mi
Prevail Global StudyN/A<1 mi
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)Phase 3<1 mi
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic DysfunctionPhase 3<1 mi
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)N/A<1 mi
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE<1 mi
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial FibrillationN/A<1 mi
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMRN/A<1 mi
Product Surveillance Registry<1 mi
Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF StudyN/A<1 mi
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPhase 3<1 mi
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2Phase 3<1 mi
TTVR Early Feasibility StudyN/A<1 mi
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in WomenN/A<1 mi
TVMR With the INNOVALVE System Trial - Early Feasibility StudyN/A<1 mi
Assessment of CCM in HF With Higher Ejection FractionN/A<1 mi
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina IIN/A<1 mi
Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)Phase 2<1 mi
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.N/A<1 mi
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and ChemotherapyPhase 3<1 mi
Quality of Pediatric Resuscitation in a Multicenter Collaborative<1 mi
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve ReplacementN/A<1 mi
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)N/A<1 mi
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial FibrillationPhase 3<1 mi
PULSED AF Post-Approval Study<1 mi
Addressing Under-treatment and Health Equity in AS and MR Using an Integrated EHR PlatformN/A<1 mi
Heart Attack Research Program- Imaging Study<1 mi
ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt SystemN/A<1 mi
Autus Valve Pivotal StudyN/A<1 mi
Congenital Heart Disease Physical Activity Lifestyle Study V.2N/A<1 mi
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical TrialN/A<1 mi
Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular GraftsPhase 2<1 mi
Effects of Ketone Ester Consumption on Exercise Tolerance and Cardiac FunctionN/A<1 mi
Effects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea<1 mi
EFS of the DUO System for Tricuspid RegurgitationN/A<1 mi
An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart FailureN/A<1 mi
Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation<1 mi
Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)N/A<1 mi
SPHERE Per-AF Post-Approval Study<1 mi
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEFPhase 3<1 mi
Women's Heart Attack Research Program: Stress Ancillary StudyN/A<1 mi
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart FailurePhase 4<1 mi
IPSC Repository of Pediatric Cardiovascular Disease<1 mi
Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry<1 mi
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart FailureN/A<1 mi
The PulsePoint StudyN/A<1 mi
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve DysfunctionN/A<1 mi
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVRN/A<1 mi
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE StudyN/A<1 mi
Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary BypassPhase 3<1 mi
Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight InfantsN/A<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing DialysisPhase 2/3<1 mi
Genetics of Congenital Heart Disease<1 mi
Minima Stent System Post- Approval Study (PAS)<1 mi
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation SystemN/A<1 mi
AI Powered Mapping Technology for Identifying Arrhythmias<1 mi
Optimal Ventilation for Cardiac ArrestN/A<1 mi
Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenital Heart Disease<1 mi
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinPhase 3<1 mi
PREEMIE: Study for Treatment of PDA in Premature InfantsN/A<1 mi
Cord Clamping Among Neonates With Congenital Heart DiseaseN/A<1 mi
Pediatric Prehospital Airway Resuscitation TrialN/A<1 mi
Effect of Fetal Aortic Valvuloplasty on Outcomes<1 mi
Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate CancerPhase 2<1 mi
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular RiskPhase 3<1 mi
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - WomenPhase 3<1 mi
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF StudyN/A<1 mi
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)<1 mi
Abbott Vascular Medical Device Registry<1 mi
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve StenosisPhase 2<1 mi
Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation<1 mi
A Study of SGT-212 Gene Therapy in Friedreich's AtaxiaPhase 1<1 mi
Cardiac Sarcoidosis Randomized TrialPhase 3<1 mi
Williams Syndrome (WS) and Supravalvar Aortic Stenosis (SVAS) DNA and Tissue Bank<1 mi
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEmN/A<1 mi
Ultrafiltration Versus IV Diuretics in Worsening Heart FailureN/A<1 mi
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)N/A<1 mi
Ketogenic Diet vs Mixed Diet in Patients With Heart FailureN/A<1 mi
The CONFORM Pivotal TrialN/A<1 mi
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™N/A<1 mi
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - MinoritiesPhase 3<1 mi
ELEVATE-HFpEF Clinical StudyN/A<1 mi
Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Ancillary Study<1 mi
Pivotal Study for the Cardiac Performance System (CPS)<1 mi
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension SystemN/A<1 mi
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma<1 mi
Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues<1 mi
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPhase 3<1 mi
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)<1 mi
Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy<1 mi
ELUCIDATE FFRct Study<1 mi
ENABLE-HCM - AI-ENabled Echocardiography With Ultrasound Beyond the Echo Lab for Better HCM Imaging and Expanded Access<1 mi
ASCEND CSP IDE StudyN/A<1 mi
Validation of Belun Ring Gen3 Deep Learning Algorithms With Subxiphoid Body SensorN/A<1 mi
A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)Phase 1<1 mi
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary LesionsN/A<1 mi
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic CardiomyopathyPhase 3<1 mi
Project 3: ACHIEVE- CHDN/A<1 mi
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) TrialPhase 4<1 mi
The Half Moon Transcatheter Mitral Valve Repair (TMVr) Pilot StudyN/A<1 mi
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVCPhase 1<1 mi
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACSPhase 3<1 mi
Novel Characterization of Sex Specific Biologic Signatures in Valvular Heart Disease<1 mi
Comparative Imaging Assessment of Valvular Heart Disease<1 mi
Early Assessment and Initiation of GuideLine-Directed Evidence-Based Management-HF<1 mi
Pulsed Field Ablation for Post-Infarction Ventricular TachycardiaN/A<1 mi
Low Voltage-Directed Catheter Ablation for Atrial FibrillationN/A<1 mi
Tracking Results of Ablations to Combat AF Registry Generation 2<1 mi
Impact of Bromocriptine on Clinical Outcomes for Peripartum CardiomyopathyPhase 4<1 mi
Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) StudyPhase 4<1 mi
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureN/A<1 mi
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and IIIN/A<1 mi
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm InfantsN/A<1 mi
An Open-Label Pilot Study of VTX2735 in Recurrent PericarditisPhase 2<1 mi
Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables<1 mi
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the HeartPhase 3<1 mi
EFS of the CardioMech MVRSN/A<1 mi
Sleep Apnea Triggers of Atrial Fibrillation: N-of-1 Randomized Control Trial (SPARTA):N/A<1 mi
International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry<1 mi
A Cardiac Disease Quality of Life Study<1 mi
Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous Saline Thermodilution<1 mi
ATrial Tachycardia PAcing Therapy in Congenital Heart<1 mi
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small VesselsN/A<1 mi
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)<1 mi
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart FailureN/A<1 mi
Medtronic Cardiac Surgery PMCF Registry<1 mi
PARTNER 3 Trial - Aortic Valve-in-ValveN/A<1 mi
Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device ImplantationN/A<1 mi
Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance<1 mi
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"N/A<1 mi
Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment<1 mi
Fluid Guided Heart Failure Treatment at the Cleveland ClinicN/A<1 mi
Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCMPhase 1/2<1 mi
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantPhase 3<1 mi
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) PatientsPhase 4<1 mi
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)Phase 3<1 mi
Cephea Early Feasibility StudyN/A<1 mi
Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse<1 mi
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney DiseasePhase 3<1 mi
A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart FailureN/A<1 mi
Quantra Point-of-Care Hemostasis MonitoringN/A<1 mi
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel DiseaseN/A<1 mi
Left vs Left Randomized Clinical TrialN/A<1 mi
Intracardiac Echocardiography Guided Watchman Device ImplantN/A<1 mi
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled StudyPhase 2/3<1 mi
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery LesionsN/A<1 mi
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)Phase 3<1 mi
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious InfectionsPhase 3<1 mi
Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers<1 mi
CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting<1 mi
Surveillance Trial of the Apple Watch in Reliable Burden Assessment in Unseen Recurrence of Surgically Treated AF<1 mi
Trisol System EFS StudyN/A<1 mi
HCMR Re-Imaging Study<1 mi
CTSN Embolic Protection TrialN/A<1 mi
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)N/A<1 mi
MRI in Transcatheter Aortic Valve Replacement PatientsN/A<1 mi
Abatacept in Immune Checkpoint Inhibitor MyocarditisPhase 3<1 mi
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)N/A<1 mi
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)N/A<1 mi
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic ValvesN/A<1 mi
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis<1 mi
Phase 2/3 Study of KPL-387 in Recurrent PericarditisPhase 2/3<1 mi
TIRzepatide for the Treatment of Obesity in Patients With Atrial FibrillationPhase 2<1 mi
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)Phase 2/3<1 mi
PRIMARY Ancillary SubstudyN/A<1 mi
Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study<1 mi
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionPhase 3<1 mi
The Fourth Left Atrial Appendage Occlusion StudyN/A<1 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPhase 4<1 mi
AltaValve Pivotal TrialN/A<1 mi
TECTONIC CAD IVL IDE StudyN/A<1 mi
CV Imaging of Metabolic Interventions<1 mi
Study of JK07 in Patients With Chronic Heart FailurePhase 2<1 mi
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)Phase 3<1 mi
Development of CIRC Technologies<1 mi
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)<1 mi
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)N/A<1 mi
Biospecimen Repository for Cardiac Arrhythmias at the Cleveland Clinic<1 mi
A Nurse-Led Weight Monitoring Intervention For Heart Failure Quality of LIfe and Self-CareN/A18 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsN/A30 mi
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment30 mi
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionPhase 343 mi
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular InterventionPhase 443 mi
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With AnticoagulationPhase 244 mi
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart FailurePhase 344 mi
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and InflammationPhase 344 mi
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular EventsPhase 344 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.